NightHawk Biosciences Inc :Jeffrey Wolf - On August 18, Submitted Preliminary Non-Binding Offer Letter To Board Of Nighthawk Biosciences Inc For Starlight.Jeffrey Wolf - Offer Letter To Acquire All Equity Interest Of Nighthawk Biosciences’ Unit, Elusys Therapeutics, Inc. And Its On-Going Operations.Jeffrey Wolf-Offer Letter To Acquire All Intellectual Property Related To Early-Stage Biodefense,Research Assets Currently Being Developed By Nighthawk.Jeffrey Wolf- May Respond To Inquiries From Nighthawk And Board Or Their Representatives And Engage In Discussions And Negotiations.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。